Company profile
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects. Its lead prescription product candidate, Sublingual High Dose Aspirin, targets pain
- CEO
- —
- Headquarters
- Estero, FL, United States
- Employees
- 0
- IPO date
- Apr 11, 2022
- Sector
- Consumer Cyclical
- Industry
- Auto Parts